Japan's Regulatory Authority Approves Biogen/Eisai's Alzheimer Treatment Leqembi - Eisai Co (OTC:ESALF), Biogen (NASDAQ:BIIB)

Eisai Co Ltd (OTC: ESALY) (OTC: ESALF) and Biogen Inc (NASDAQ: BIIB) announced that humanized anti-soluble aggregated amyloid-beta (A&be

Related Keywords

Japan , ,Ad Cooperative Study ,Biogen Inc ,Eisai Co Ltd ,Leqembi Intravenous Infusion ,Daily Living Scale ,Mild Cognitive Impairment ,